dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Cárcel-Márquez, Jara |
dc.contributor.author | Gallego-Fabrega, Cristina |
dc.contributor.author | Llucià-Carol, Laia |
dc.contributor.author | Alvarez Sabin, José |
dc.contributor.author | Molina Cateriano, Carlos |
dc.contributor.author | Ribó Jacobi, Marc |
dc.contributor.author | Delgado Martínez, Maria Pilar |
dc.contributor.author | Muiño, Elena |
dc.contributor.author | Cullell, Natalia |
dc.contributor.author | Lledós, Miquel |
dc.date.accessioned | 2022-10-06T12:37:29Z |
dc.date.available | 2022-10-06T12:37:29Z |
dc.date.issued | 2022-07-08 |
dc.identifier.citation | Cárcel-Márquez J, Muiño E, Gallego-Fabrega C, Cullell N, Lledós M, Llucià-Carol L, et al. A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype. Front Cardiovasc Med. 2022 Jul 8;9:940696. |
dc.identifier.issn | 2297-055X |
dc.identifier.uri | https://hdl.handle.net/11351/8271 |
dc.description | Anàlisi de múltiples trets; Puntuació de risc poligènic; Ictus |
dc.description.sponsorship | J. Cárcel-Márquez has received funding through an AGAUR Contract (Agència de Gestió d'Ajuts Universitaris i de Recerca; FI_DGR 2019, grant number 2020FI_B1 00157) co-financed with Fons Social Europeu (FSE) (https://agaur.gencat.cat). From Instituto de Salud Carlos III: E. Muiño is funded by a Río Hortega Contract (CM18/00198), M. Lledós is funded by a PFIS Contract (Contratos Predoctorales de Formación en Investigación en Salud, FI19/00309), C. Gallego-Fabrega is supported by a Sara Borrell Contract (CD20/00043) and Fondo Europeo de Desarrollo Regional (ISCIII-FEDER), T. Sobrino (CPII17/00027), and F. Campos (CPII19/00020) are recipients of research contracts from the Miguel Servet Program (https://www.isciii.es). This study has been funded by Instituto de Salud Carlos III PI15/01978, PI17/02089, PI18-01338, and RICORS-ICTUS RD21/0006/0006 (Instituto de Salud Carlos III), by Marató TV3 support of the Epigenesis study (https://www.ccma.cat/tv3/marato/), by the Fundació Docència i Recerca FMT grant for the Epigenesis project (https://www.mutuaterrassa.com), by Eranet-Neuron of the Ibiostroke project (AC19/00106) (https://www.neuron-eranet.eu), by Boehringer Ingelheim of the SEDMAN Study (https://www.boehringer-ingelheim.it), and GCAT Cession Research Project PI-2018-01 (http://www.gcatbiobank.org). GCAT was funded by Acción de Dinamización del ISCIII-MINECO and the Ministry of Health of the Generalitat of Catalunya (ADE 10/00026); and have additional suport by the Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) (2017-SGR 529). |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Cardiovascular Medicine;9 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Anticoagulants (Medicina) - Ús terapèutic |
dc.subject | Embòlia |
dc.subject | Fibril·lació auricular - Complicacions |
dc.subject.mesh | Atrial Fibrillation |
dc.subject.mesh | Embolism |
dc.subject.mesh | Anticoagulants |
dc.title | A Polygenic Risk Score Based on a Cardioembolic Stroke Multitrait Analysis Improves a Clinical Prediction Model for This Stroke Subtype |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fcvm.2022.940696 |
dc.subject.decs | fibrilación atrial |
dc.subject.decs | embolia |
dc.subject.decs | anticoagulantes |
dc.relation.publishversion | https://doi.org/10.3389/fcvm.2022.940696 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Cárcel-Márquez J] Stroke Pharmacogenomics and Genetics Group, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Muiño E, Lledós M] Stroke Pharmacogenomics and Genetics Group, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain. [Gallego-Fabrega C] Stroke Pharmacogenomics and Genetics Group, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain. Stroke Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [Cullell N] Stroke Pharmacogenomics and Genetics Group, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain. Stroke Pharmacogenomics and Genetics Laboratory, Fundación Docència i Recerca Mútua Terrassa, Hospital Mútua Terrassa, Terrassa, Spain. [Llucià-Carol L] Stroke Pharmacogenomics and Genetics Group, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain. Departament de Genètica i de Microbiologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Álvarez-Sabín J, Molina CA, Ribó M] Unitat d’Ictus i Hemodinàmica Cerebral, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Delgado P] Laboratori de Recerca Neurovascular, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 35872910 |
dc.identifier.wos | 000830113500001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |